Evidence map›Paper›PMID 28947376›Full record

ArticleNeuropharmacology2018

Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood.

Jonathan Henry W Jacobsen, Femke T Buisman-Pijlman, Sanam Mustafa, Kenner C Rice, Mark R Hutchinson

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Toll-Like Receptor 4: A Novel Target to Tackle Drug Addiction?Handbook of experimental pharmacology · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Neuroimmune signaling in alcohol use disorder.Pharmacology, biochemistry, and behavior · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jonathan Henry W JacobsenDiscipline of Pharmacology, Adelaide Medical School, University of Adelaide, South Australia, Australia. Electronic address: jonathan.jacobsen@adelaide.edu.au.
Femke T Buisman-PijlmanDiscipline of Pharmacology, Adelaide Medical School, University of Adelaide, South Australia, Australia.
Sanam MustafaDiscipline of Physiology, Adelaide Medical School, University of Adelaide, South Australia, Australia; ARC Centre of Excellence for Nanoscale BioPhotonics, University of Adelaide, South Australia, Australia.
Kenner C RiceDrug Design and Synthesis Section, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, United States.
Mark R HutchinsonDiscipline of Physiology, Adelaide Medical School, University of Adelaide, South Australia, Australia; ARC Centre of Excellence for Nanoscale BioPhotonics, University of Adelaide, South Australia, Australia. Electronic address: mark.hutchinson@adelaide.edu.au.
University of Adelaide · AUNational Institute on Alcohol Abuse and Alcoholism · US

Funding

Medicinal Chemistry of Drugs Acting on Toll-like ReceptorsZIADA000530 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.0M
Medicinal Chemistry of Drugs Acting on Toll-like ReceptorsZ01DA000530 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2008 to 2008
$95k
Intramural NIH HHS Z01 DA000530
6 · The paper itself

Abstract

Adolescents frequently engage in risky behaviours such as binge drinking. Binge drinking, in turn, perturbs neurodevelopment reinforcing reward seeking behaviour in adulthood. Current animal models are limited in their portrayal of this behaviour and the assessment of neuroimmune involvement (specifically the role of Toll-like receptor 4 (TLR4)). Therefore, the aims of this project were to develop a more relevant animal model of adolescent alcohol exposure and to characterise its effects on TLR4 signalling and alcohol-related behaviours later life. Balb/c mice received a short (P22-P25), low dose alcohol binge during in early adolescence, and underwent tests to investigate anxiety (elevated plus maze), alcohol seeking (conditioned place preference) and binge drinking behaviour (drinking in the dark) in adulthood. Four doses of alcohol during adolescence increased alcohol-induced conditioned place preference and alcohol intake in adulthood. However, this model did not affect basal elevated plus maze performance. Subsequent analysis of nucleus accumbal mRNA, revealed increased expression of TLR4-related mRNAs in mice who received alcohol during adolescence. To further elucidate the role of TLR4, (+)-Naltrexone, a biased TLR4 antagonist was administered 30 min before or after the adolescent binge paradigm. When tested in adulthood, (+)-Naltrexone treated mice exhibited reduced alcohol intake however, alcohol seeking and anxiety behaviour was unaltered. This study highlights that even a small amount of alcohol, when given during a critical neurodevelopmental period, can potentiate alcohol-related behaviours and TLR4 activation later in life. Interestingly, attenuation of TLR4 before or after adolescent alcohol exposure reduced only binge alcohol intake in adulthood.

Indexed as

Binge DrinkingAdaptor Proteins, Vesicular TransportAnimalsAnimals, NewbornCentral Nervous System DepressantsDose-Response Relationship, DrugDrug-Seeking BehaviorEthanolFemalegamma-Aminobutyric AcidMiceMice, Inbred BALB CNaltrexonePregnancyRNA, MessengerSignal TransductionAdaptor Proteins, Vesicular TransportCentral Nervous System DepressantsEthanolgamma-Aminobutyric AcidNaltrexoneRNA, MessengerTicam1 protein, mouseToll-Like Receptor 4AdolescentAlcoholGABANeurodevelopmentNeuroimmuneToll-like receptor 4TRIF

Identifiers

PMID28947376
PMCPMC7387100
OpenAlexW2757128101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.